Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
- Source
- The Economic Times - General
- Source link
- https://economictimes.indiatimes.com/markets/us-stocks/wall-street-guide/moderna-shares-soar-135-in-a-day-after-cancer-vaccine-succeeds-in-late-stage-trial/articleshow/133351080.cms
- Published
- 2026-08-19 14:26:33
- Discovered by ProcIntel
- 2026-08-19 16:01:14
- Category
- Procurement & Supply Chain News
- Geography
- India
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This marks the first successful late-stage trial for an mRNA cancer vaccine. The findings offer hope for future growth beyond COVID-19 vaccines. Discussions with regulators are expected within the next few months.
Procurement Relevance Gate
FAIL
— score 7.0/100 — evaluated 2026-08-19 16:01:14
Only geographic exposure matched — no substantive content indicator, so this cannot pass alone.
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.